uspto-grants-2002_04
uspto-grants-2002_04 · 10.6084/m9.figshare.5104873.v1 · US06372457B1
查看条件与参与物IDENTITY
COMPUTED
PROPERTIES
911 mg/mL
Very soluble in water; [Merck Index]
Solid
150 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine]
154.2 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
156.44 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field];148.02 Ų [M-H]- [CCS Type: DT; Method: stepped-field]
154.4 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];144.1 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)];154.9 Ų [M+Na-2H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
146.1 Ų [M-H]-;154.8 Ų [M-2H+Na]-;154.3 Ų [M+Na]+;155.2 Ų [M+Na]+;144.3 Ų [M-H]-
PHARMACOLOGY
Intestine;Prostate
Cytoplasm
2-Hydroxyglutric Aciduria (D And L Form);4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency;Amino Sugar Metabolism;Fanconi-bickel syndrome;Fructose and mannose metabolism;Fructose intolerance, hereditary;Fructose-1,6-diphosphatase deficiency;Fructosuria;G(M2)-Gangliosidosis: Variant B, Tay-sachs disease;Glucose-6-phosphate dehydrogenase deficiency;Total 30 pathways, visit the HMDB page for details
USES
Present in animal tissues as an equilibrium mixture with glucose-6-phosphate. [Merck Index]
D-Fructose, 6-(dihydrogen phosphate): INACTIVE
ALIASES
REACTIONS
uspto-grants-2002_04
uspto-grants-2002_04 · 10.6084/m9.figshare.5104873.v1 · US06372457B1
查看条件与参与物uspto-grants-2015_10
uspto-grants-2015_10 · 10.6084/m9.figshare.5104873.v1 · US09169502B2
查看条件与参与物uspto-grants-1992_09
uspto-grants-1992_09 · 10.6084/m9.figshare.5104873.v1 · US05147776
查看条件与参与物